We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+8.24%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$3.42B
AUM Growth
+$501M
Cap. Flow
+$282M
Cap. Flow %
8.25%
Top 10 Hldgs %
57.34%
Holding
3,480
New
198
Increased
1,425
Reduced
1,113
Closed
202

Sector Composition

Rank Sector Weight
1 Technology 5.85%
2 Financials 3.84%
3 Healthcare 3.64%
4 Consumer Discretionary 3.24%
5 Consumer Staples 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASPN icon
3026
Aspen Aerogels
ASPN
$374M
$755 ﹤0.01%
64
BBUC
3027
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.5B
$752 ﹤0.01%
+40
New +$870
COGT icon
3028
Cogent Biosciences
COGT
$7.07B
$751 ﹤0.01%
65
-15
-19% -$186
FNDC icon
3029
Schwab Fundamental International Small Company Index ETF
FNDC
$3.07B
$750 ﹤0.01%
24
GDRX icon
3030
GoodRx Holdings
GDRX
$1.07B
$746 ﹤0.01%
160
+113
+240% +$557
SPFI icon
3031
South Plains Financial
SPFI
$842M
$743 ﹤0.01%
27
ZETA icon
3032
Zeta Global
ZETA
$5.33B
$743 ﹤0.01%
91
GBX icon
3033
The Greenbrier Companies
GBX
$1.52B
$738 ﹤0.01%
22
-4
-15% -$133
LGF.B
3034
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$738 ﹤0.01%
136
AKTS
3035
DELISTED
Akoustis Technologies Inc
AKTS
$736 ﹤0.01%
261
-4,000
-94% -$12.6K
RNAM
3036
DELISTED
Avidity Biosciences
RNAM
$732 ﹤0.01%
33
-107
-76% -$1.59K
SWTX
3037
DELISTED
SpringWorks Therapeutics
SWTX
$728 ﹤0.01%
28
-241
-90% -$5.94K
CBAY
3038
DELISTED
Cymabay Therapeutics
CBAY
$727 ﹤0.01%
+116
New +$441
KNTE
3039
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$726 ﹤0.01%
119
-846
-88% -$6.89K
PROK icon
3040
ProKidney
PROK
$324M
$720 ﹤0.01%
105
+45
+75% +$430
ARKW icon
3041
ARK Web x.0 ETF
ARKW
$1.65B
$715 ﹤0.01%
19
-168
-90% -$7.35K
CAL icon
3042
Caleres
CAL
$437M
$713 ﹤0.01%
32
-201
-86% -$4.93K
CLDX icon
3043
Celldex Therapeutics
CLDX
$3.02B
$713 ﹤0.01%
+16
New +$571
CENT icon
3044
Central Garden & Pet Co
CENT
$2.71B
$712 ﹤0.01%
24
-16
-40% -$506
PRVB
3045
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$708 ﹤0.01%
+67
New +$541
REPX icon
3046
Riley Exploration Permian
REPX
$727M
$706 ﹤0.01%
+24
New +$682
AQN icon
3047
Algonquin Power & Utilities
AQN
$4.6B
$704 ﹤0.01%
108
-52
-33% -$464
ALEC icon
3048
Alector
ALEC
$180M
$701 ﹤0.01%
76
-162
-68% -$1.41K
ECHO
3049
EchoStar
ECHO
$25B
$701 ﹤0.01%
+42
New +$728
UIS icon
3050
Unisys
UIS
$230M
$700 ﹤0.01%
+137
New +$859

Similar funds

SignatureFD's Q4 2022 Portfolio in Review

As of Q4 2022, SignatureFD held 3,480 positions worth $3.42B, up 17% from $2.92B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

SignatureFD deployed $282M of net new capital in Q4 2022, opening 198 new positions and adding to 1,425 existing holdings. Its largest new stake was JPMorgan Ultra-Short Municipal Income ETF: 9,739 shares worth $492K.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $32.2M trimmed.

  • SignatureFD's largest Q4 2022 buy was JPMorgan Ultra-Short Municipal Income ETF: 9,739 shares worth $492K.
  • SignatureFD added most to iShares National Muni Bond ETF in Q4 2022, an estimated $81.3M increase.
  • SignatureFD's biggest Q4 2022 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $32.2M.
  • SignatureFD fully exited Twitter, Inc. in Q4 2022, selling an estimated $777K.
  • SignatureFD's ten largest holdings make up 57% of its $3.42B portfolio in Q4 2022.
  • SignatureFD opened 198 new positions and closed 202 in Q4 2022.
  • SignatureFD's portfolio value rose 17% quarter-over-quarter to $3.42B.

Based on SignatureFD's 13F filing for Q4 2022, filed 30 Jan 2023.